- Home
- DCGO vs OSUR Comparison
DCGO vs OSUR Comparison
Compare DCGO & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- OSUR
- Stock Information
- Founded
- DCGO 2015
- OSUR 2000
- Country
- DCGO United States
- OSUR United States
- Employees
- DCGO N/A
- OSUR N/A
- Industry
- DCGO Managed Health Care
- OSUR Medical/Dental Instruments
- Sector
- DCGO Health Care
- OSUR Health Care
- Exchange
- DCGO Nasdaq
- OSUR Nasdaq
- Market Cap
- DCGO 327.4M
- OSUR 334.1M
- IPO Year
- DCGO N/A
- OSUR 1986
- Fundamental
- Price
- DCGO $3.42
- OSUR $4.10
- Analyst Decision
- DCGO Strong Buy
- OSUR Buy
- Analyst Count
- DCGO 5
- OSUR 3
- Target Price
- DCGO $6.10
- OSUR $6.67
- AVG Volume (30 Days)
- DCGO 431.0K
- OSUR 485.4K
- Earning Date
- DCGO 11-07-2024
- OSUR 11-05-2024
- Dividend Yield
- DCGO N/A
- OSUR N/A
- EPS Growth
- DCGO 393.09
- OSUR N/A
- EPS
- DCGO 0.28
- OSUR 0.36
- Revenue
- DCGO $742,836,424.00
- OSUR $273,535,000.00
- Revenue This Year
- DCGO $1.17
- OSUR N/A
- Revenue Next Year
- DCGO N/A
- OSUR N/A
- P/E Ratio
- DCGO $12.35
- OSUR $11.49
- Revenue Growth
- DCGO 64.49
- OSUR N/A
- 52 Week Low
- DCGO $2.75
- OSUR $3.92
- 52 Week High
- DCGO $6.90
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- DCGO 53.79
- OSUR 45.49
- Support Level
- DCGO $3.20
- OSUR $4.00
- Resistance Level
- DCGO $3.47
- OSUR $4.16
- Average True Range (ATR)
- DCGO 0.15
- OSUR 0.08
- MACD
- DCGO 0.03
- OSUR 0.01
- Stochastic Oscillator
- DCGO 87.80
- OSUR 57.89
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.